EA200700760A1 - MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASES - Google Patents

MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASES

Info

Publication number
EA200700760A1
EA200700760A1 EA200700760A EA200700760A EA200700760A1 EA 200700760 A1 EA200700760 A1 EA 200700760A1 EA 200700760 A EA200700760 A EA 200700760A EA 200700760 A EA200700760 A EA 200700760A EA 200700760 A1 EA200700760 A1 EA 200700760A1
Authority
EA
Eurasian Patent Office
Prior art keywords
prostate gland
treatment
agent
proposed
ratio
Prior art date
Application number
EA200700760A
Other languages
Russian (ru)
Other versions
EA010427B1 (en
Inventor
Рустам Мунирович Иксанов
Лидия Алексеевна Усоева
Людмила Валентиновна Моругина
Original Assignee
Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм")
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм") filed Critical Открытое Акционерное Общество "Нижегородский Химико-Фармацевтический Завод" (Оао "Нижфарм")
Priority to EA200700760A priority Critical patent/EA200700760A1/en
Publication of EA010427B1 publication Critical patent/EA010427B1/en
Publication of EA200700760A1 publication Critical patent/EA200700760A1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Изобретение относится к медицине и фармацевтической промышленности, в частности к созданию новых лекарственных средств для лечения заболеваний мочеполовой системы. Предлагаемое средство для лечения заболеваний предстательной железы, выполненное в виде суппозитория, содержащее комплекс биорегуляторных пептидов предстательной железы крупного рогатого скота в форме порошка с содержанием водорастворимых пептидов не менее 20%, антимикробное средство, представляющее собой антибиотик, или противовирусное средство, или противопротозойное средство, или смесь антибиотика и противопротозойного средства, взятых в соотношении 1:1, или смесь противовирусного и противопротозойного средств, взятых в соотношении 1:1, и основу, при следующем соотношении компонентов, г на одну свечу: комплекс биорегуляторных пептидов предстательной железы крупного рогатого скота - 0,05-0,4, антимикробное средство - не более 0,7, основа - достаточное количество для получения суппозитория массой 2,15-2,35 г. В качестве основы для получения предлагаемого средства используется любая фармацевтически приемлемая основа, например витепсол, твердый жир, масло какао. Как показали проведенные исследования, предлагаемое средство в виде суппозиториев обладает высоким уровнем органотропной активности и высоким уровнем антимикробного действия.The invention relates to medicine and the pharmaceutical industry, in particular to the creation of new medicines for the treatment of diseases of the urogenital system. The proposed remedy for the treatment of diseases of the prostate gland, made in the form of a suppository, containing a complex of bioregulatory peptides of the prostate gland of cattle in the form of a powder with a content of water-soluble peptides of at least 20%, an antimicrobial agent, which is an antibiotic, or antiviral agent, or antiprotozoan, or a mixture of antibiotic and antiprotozoal agents, taken in a 1: 1 ratio, or a mixture of antiviral and antiprotozoa drugs, taken in a ratio ii 1: 1, and the basis, in the following ratio of components, g per candle: complex of bioregulatory peptides of the prostate gland of cattle - 0.05-0.4, antimicrobial agent - not more than 0.7, base - enough for suppository weighing 2.15-2.35 g. Any pharmaceutically acceptable base is used as the basis for obtaining the proposed agent, for example, witepsol, tallow, cocoa butter. As studies have shown, the proposed tool in the form of suppositories has a high level of organotropic activity and a high level of antimicrobial action.

EA200700760A 2007-04-27 2007-04-27 MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASES EA200700760A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EA200700760A EA200700760A1 (en) 2007-04-27 2007-04-27 MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EA200700760A EA200700760A1 (en) 2007-04-27 2007-04-27 MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASES

Publications (2)

Publication Number Publication Date
EA010427B1 EA010427B1 (en) 2008-08-29
EA200700760A1 true EA200700760A1 (en) 2008-08-29

Family

ID=40849032

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200700760A EA200700760A1 (en) 2007-04-27 2007-04-27 MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASES

Country Status (1)

Country Link
EA (1) EA200700760A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8642079B2 (en) * 2004-02-23 2014-02-04 Hormos Medical Corporation Solid formulations of ospemifene
RU2640931C1 (en) * 2017-03-23 2018-01-12 Закрытое акционерное общество "ФАРМ-ХОЛДИНГ" Rectal suppositories for prostate treatment containing lysyl-glutamyl-aspartyl-proline tetrapeptide

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2112504C1 (en) * 1996-12-24 1998-06-10 Открытое акционерное общество "Нижегородский химико-фармацевтический завод" Agent "vitaprost" for prostate gland disease treatment
RU2160114C1 (en) * 1999-10-06 2000-12-10 Государственное унитарное предприятие "Иммунопрепарат" Rectal means for treating chronic prostatitis
KR100438416B1 (en) * 2001-09-19 2004-07-02 학교법인조선대학교 Novel peptides with increased + charge and hydrophobicity by substituting one or more amino acids of CA-MA peptide and pharmaceutical compositions containing thereof
HU0104790D0 (en) * 2001-11-08 2002-01-28 Human Rt Pharmaceutical combinations for topical application
RU2278675C1 (en) * 2005-01-17 2006-06-27 Юрий Борисович Иванов Antibacterial agent and pharmaceutical composition comprising effective amount of antibacterial agent

Also Published As

Publication number Publication date
EA010427B1 (en) 2008-08-29

Similar Documents

Publication Publication Date Title
TW200619220A (en) New hydrates and polymorphs of 4-[[(7r)-8-cyclopentyl-7-ethyl-5, 6, 7, 8-tetrahydro-5-methyl-6-oxo-2-pteridinyl]amino]-3-mithoxy-n-(1-methyl-4-piperidinyl)-benzamide, process for their manufacture and their use as medicament
TW200510429A (en) Heterocyclic MCHR1 antagonists
IL176007A0 (en) Antibodies specific to c35 and pharmaceutical compositions containing the same
UA83659C2 (en) P2x7 receptor antagonists and their use, pharmaceutical composition based thereon, process for the preparation thereof (variants)
MY157661A (en) Bendamustine pharmaceutical compositions
IL187328A (en) N-methyl-2-fluoro-{4-[3-(4-cyano-3-trifluoromethylphenyl)-5,5-dimethyl-4-oxo-2-thioxo-imidazolidin-1-yl]}benzamide, pharmaceutical compositions comprising the same and uses thereof in the manufacture of medicaments
HRP20050735B1 (en) Dihydropteridinones, method for the production and use thereof in the form of drugs
TNSN07005A1 (en) TETRAPEPTITIIC ANALOGS
MXPA05010682A (en) Novel compounds.
TW200634003A (en) Chemical compounds
GEP20084466B (en) Beta d-crystalline form of ivabradine hydrochloride, a process for its preparation and pharmaceutical compositions containing it
TW200519075A (en) Novel compounds
GB0625648D0 (en) Compounds
UA104988C2 (en) Novel pyrone-indole derivatives and process for their preparation
TW200745122A (en) New compounds I
TW200738659A (en) Novel compounds
PL2018170T3 (en) Medication against breast cancer
MXPA05011076A (en) Chemical compounds.
BRPI0518789A2 (en) pharmaceutical formulation, process for preparing a pharmaceutical formulation, product, and capsule or tablet
UA86441C2 (en) (2-hydroxyethyl)trimethylammonium thiooctate (choline thioctate), having hepatoprotective, hypoamoniemic and detoxic action, method for production thereof and pharmaceutical compositions based on it
BRPI0518786A2 (en) pharmaceutical formulation, process for preparing a pharmaceutical formulation, product, and capsule or tablet
TW200505452A (en) Chemical compounds
PL1831239T3 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid lambda-lactone and key-intermediates for this process
TW200640465A (en) New pharmaceutically active compounds for the treatment of respiratory diseases
EA200700760A1 (en) MEANS FOR THE TREATMENT OF THE PROSTATE GLAND DISEASES

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): RU

TC4A Change in name of a patent proprietor in a eurasian patent
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM